India’s first indigenous CAR-T cell therapy, NexCAR19, developed by ImmunoACT, an IIT Bombay spin-off, marks a major leap in ...

During the July-September quarter, Metropolis’s B2B business reported 33 per cent growth, while B2C revenue inched up 16 per ...

A groundbreaking study by IIT Bombay identifies blood biomarkers for early detection of diabetic kidney disease, paving the ...

A recent study highlights that Delhi is the sixth most polluted city in October, with a significant rise in PM2.5 levels.

Niva Bupa Health Insurance Company Ltd sees remarkable growth with Q2 net profit soaring to Rs 62 crore, a significant ...

Amid a prolonged federal government shutdown, the Trump administration has earmarked $450 million in tariff revenue for the ...

Discover how India is transforming affordable diagnostics, expanding healthcare access beyond major cities, and leveraging ...

The Public Works Department (PWD) in Delhi is set to install automatic mist spraying systems at three major pollution ...

Novo Holdings, the investment arm of Novo Nordisk, is increasing its focus on India's healthcare sector by investing in ...

MedGenome has announced a strategic investment in Green Cross Genetics Lab to enhance diagnostic services across India, ...

The World Health Organization calls for immediate action to tackle the global health financing crisis as countries face ...

The Delhi High Court has dismissed a plea from Dr Reddy's Laboratories challenging the FSSAI's ban on using 'ORS' branding ...